PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020
In an effort to build research capacity in Vietnam, this cooperative agreement has identified Hanoi Medical University (HMU) which has significant experience in research and evaluation capacity-building, design, and implementation. To utilize local expertise and resources, CDC is formalizing its collaboration with HMU starting in 2012 to support the national HIV program at central, regional and provincial levels. Through its own connections with faculties, students and with other medical universities nationally, the grantee is expected to bring additional human resources from the academic setting to support the HIV system.
The grantee will serve as a supporter to existing research institutions to implement HIV/AIDS program evaluations and operations research identified by GVN and stakeholders. The goal of this mechanism is to promote research and evaluation on HIV/AIDS in Vietnam and strengthen sustained linkage between academia and program implementers. CDC staff will closely work with grantee to provide technical assistance and monitoring of activities on a monthly basis.
HMU will also collaborate with CDC and MOLISA in an effort to develop and advance HIV prevention efforts and Strategic Information Systems, to Support Drug Addiction Treatment in Vietnam. Specifically, HMU will evaluate a pilot model of an evidence- and community-based approach for treating opioid addiction/dependence. The goal of the evaluation will be to assess and compare routinely collected data from the 2 pilot sites for informing strategy to improve addiction treatment and support services
CDC will continue to partner with the Hanoi Medical University (HMU) laboratory Quality Control Center (QCC) to oversee quality management systems (QMS) for a national network of clinical laboratories. Through this partnership the capacity of the QCC and the lab network will be improved through intensive technical assistance from CDC to the QCC and from the QCC to provincial laboratories in areas such as enhanced testing capacity and implementation of the Strengthening Laboratory Management Towards Accreditation (SLMTA) program.
This capacity building initiative was previously funded through a sub-grant from the CDC-Vietnam Administration of Medical Services cooperative agreement to HMU but will be transferred to this the direct CDC- HMU mechanism in COP 13.
This mechanism will also support HMU to continue development of a robust training curriculum for a Bachelor of Medical Technology program, including lesson plans for lecture and laboratory exercises and assessment tools for matriculating students.
PEPFAR SI will assist HMU to focus on research and evaluation and will provide technical assistance (TA) on data use for:
1. Research and evaluation: in FY 2012, grantee will collaborate with national surveillance team to support methodology improvement of HIV surveys, surveillance. Upon request of CDC, grantee will also conduct economic analysis looking at cost effectiveness and cost efficiency of different PEPFAR activities and programs. Areas of specific need may include: evaluating optimal models of service integration for MARPs (IDU, MSM, and CSW), evaluating MARPs prevention program impact, network analysis of MARPs to profile population relationships and associated risk-factors, and evaluation of care and treatment program outcomes and associated factors, evaluation of approaches for earlier service uptake, including HIV counseling and testing and HIV/AIDS care and treatment. The grantee will also assist in the development of a cohort study to rigorously evaluate the impact of routine intervention services among MARPs. This work will be done in collaboration with HIV institutions such as NIHE and other regional institutes. In Year One, the grantee will be expected to provide a concept paper and to assist in the development of a full proposal for this study in collaboration with defined institutions.
2. Technical support will be given to M&E staff at central, regional, and provincial levels through regular site visits and quarterly meetings and reviews of current HIV surveillance data and program information such as IBBS, HSS surveys, and periodic reports. The TA covers data management, data analysis and reporting of existing M&E data.
Policy development and capacity building on CME.
HMU will collaborate with CDC and MOLISA in efforts to develop and advance HIV Prevention efforts and Strategic Information Systems, to Support Drug Addiction Treatment in Vietnam. Specifically, HMU will evaluate a pilot model of an evidence- and community-based approach for treating opioid addiction/ dependence. The goal of the evaluation will be to assess and compare routinely collected data from 2 pilot sites for informing strategy to improve addiction treatment and support services. Evaluation objectives may include:
To describe key outcomes of pilot activities (at individual, program, and system level)
To assess service delivery to patients, patient retention and adherence
To assess clinical, behavioral and social outputs and outcomes of pilot services
To assess quality, effectiveness, and/or cost of pilot services, and
To provide information for developing plans to improve program services
Program monitoring and evaluation will be based on routinely collected program level data, site visits, and program reviews. VAAC and MOLISA will be critical partners of the PEPFAR comprehensive plan for the evaluation of IDU interventions in Vietnam.
